BiotechTube
Oligo Factory

Oligo Factory

San Diego, United States· Est.
oligofactory.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Oligo Factory is a private, revenue-generating CDMO founded in 2018 and headquartered in Holliston, Massachusetts. It operates a state-of-the-art facility offering end-to-end custom oligo services—from synthesis and purification to analytics and quality control—catering to the RNA therapeutics, diagnostics, and life sciences tool sectors. The company differentiates itself through flexible scaling from micrograms to hundreds of grams, rapid turnaround, and a collaborative approach, supporting clients from research through clinical trials and commercialization. Its business is structured around three core solution brands: FactorTx™ for therapeutics, FactorDx™ for diagnostics, and FactorLS™ for life sciences.

Genetics & GenomicsRNA Therapeutics

Technology Platform

Integrated CDMO platform for custom DNA/RNA oligonucleotides, encompassing synthesis (microgram to 100+ gram scale), purification, analytics, and quality systems under ISO 13485 and ICH Q7 GMP compliance.

Opportunities

The company is positioned in the high-growth oligonucleotide therapeutics and diagnostics market, driven by increasing adoption of RNA-targeted drugs, CRISPR, and molecular diagnostics.
Its flexible GMP manufacturing and three-pronged business model (Therapeutics, Diagnostics, Life Sciences) allow it to capture revenue across the R&D continuum.

Risk Factors

Key risks include intense competition from larger, established CDMOs and tools providers, potential revenue volatility tied to biotech funding cycles, and significant execution/regulatory risk associated with GMP manufacturing for clinical-stage therapies.

Competitive Landscape

Oligo Factory competes in a crowded oligo CDMO and supplier market against giants like Danaher (IDT), Thermo Fisher, Eurofins, and LGC Biosearch, as well as other specialized manufacturers. It differentiates through a focused therapeutic partnership model, rapid turnaround, and a clear quality path from RUO to GMP.

More companies in Synthetic Biology →More companies in United States →